Home/Filings/4/0001193125-26-001097
4//SEC Filing

Tousignant Jennifer 4

Accession 0001193125-26-001097

CIK 0001590750other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 5:25 PM ET

Size

4.9 KB

Accession

0001193125-26-001097

Insider Transaction Report

Form 4
Period: 2025-12-31
Tousignant Jennifer
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2025-12-31$31.16/sh2,272$70,7960 total
Footnotes (1)
  • [F1]Consists of shares purchased under the Issuer's employee stock purchase plan.

Documents

1 file

Issuer

Viridian Therapeutics, Inc.\DE

CIK 0001590750

Entity typeother

Related Parties

1
  • filerCIK 0002010978

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 5:25 PM ET
Size
4.9 KB